Derived from the part of the cannabis plant that doesn’t get you “high” like THC, cannabidiol (CBD) is typically used for health reasons instead of for recreational purposes, and has been found to be especially useful for treating symptoms of Parkinson’s disease. A challenging neurodegenerative disorder, Parkinson’s causes a combination of motor and non-motor symptoms — such as tremors, weakness, stiffness, dizziness, anxiety and sleeplessness — that affect daily life. CBD, typically taken in oil form, has the potential to relieve these symptoms, improving sleep, reducing inflammation and more, which can profoundly help the more than 10 million people across the world suffering.
Sativa Investments PLC invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical cannabis. Their investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.